An entrepreneur who made his fortune building a $14 billion tech company is setting up a life science venture capital fund. The Israel-focused fund will target maturing life science startups with a view to helping companies grow into the next Teva ($TEVA) rather than sell up or outlicense their programs.
commences
Breaking News
Men and Women came to join again the said marathon to defend their titles and to be the best of the best.
